Laparascopic Surgery Does Not Improve Outcomes Over Open Resection for Rectal Cancer
the ONA take:
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer, two studies published in JAMA have shown.
In the first study, researchers sought to determine whether laparoscopic resection is noninferior to open resection in patients with more advanced-stage rectal cancer.
Researchers randomly assigned 240 patients to undergo laparoscopic resection and 222 to undergo open resection. Results showed that the minimally invasive surgery did not improve cancer control as well as the open surgery did.
“Pending clinical oncologic outcomes, the findings do not support the use of laparoscopic resection in these patients,” the authors of the first study conclude.
In the second study, researchers enrolled 475 patients with T1 to T3 rectal adenocarcinoma less than 15 cm from the anal verge and randomly assigned them to undergo open laparotomy and rectal resection or laparoscopic rectal resection.
Results of this study also demonstrated that laparoscopic surgery was not noninferior to open surgery for successful resection; however, overall quality of surgery was high among patients who underwent the laparoscopic surgery.
“The findings do not provide sufficient evidence for the routine use of laparoscopic surgery,” the authors of the second study conclude.
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|